Harnessing Communication Preferences (NCT07278544)
Harnessing Communication Preferences to Enhance Its Persistence and Mitigate Relapse of Challenging Behavior
🩺 Plain-English Summary (8th-Grade Level)
The goal of this clinical trial is to evaluate how preference for communication approach (e.g., using a touch talker versus picture cards) impacts treatment maintenance in the context of treatment to reduce challenging behavior exhibited by individuals with intellectual and/or developmental disabilities. As well, the clinical trial will evaluate how this preference impacts treatment relapse when care providers implement intervention and will identify potential demographic variables (e.g., age and symptom severity) that affect outcomes. The main question\[s\] it aims to answer \[is/are\]: Preferred communication strategies will persist to a greater extent when intervention is disrupted, relative to less preferred communication strategies. Communication modality preference will increase persistence for individuals with lower pre-experimental symptom severity scores and higher pre-experimental communication functioning scores. We predict demographic characteristics and developmental level will not impact intervention outcomes. Two groups will be compared. Group 1 will receive initial intervention using a preferred communication strategy. Group 2 will receive initial intervention using a non preferred, but effective, communication strategy. Intervention type will then be reversed. Researchers will compare preferred and non preferred interventions on continued expression of the communication strategy when intervention is challenged. Participants will exhibit alternative appropriate communicative behavior as a means of replacing/reducing challenging behavior. This will take place using (a) preferred communication strategies and (b) non preferred communication strategies. Following successful intervention with each type of communication, intervention will be challenged and continued use of the communication strategy will be measured.
Who can join: Review the eligibility criteria below.
Location: University of Georgia — Athens, Georgia
Age range: 2 Years to 90 Years
🧪 Interventions in This Study
- PrefFCT (BEHAVIORAL)
- NonPrefFCT (BEHAVIORAL)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (2 Sites)
- University of Georgia — Athens, Georgia
- University of Iowa — Iowa City, Iowa
📞 Contact the Study Coordinator
Phone: (319) 594-2071
Email: ringdahl@uga.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Intellectual Disability
- Improving the Health of Parents and Their Adolescent and Transition-age Youth With Intellectual and Developmental Disabilities — Carrboro, North Carolina
- Future Planning and Well-Being for Individuals With Intellectual Disabilities and Family Caregivers — New Hyde Park, New York
- Characterization of Nociception Phenotype in Individuals With Intellectual Disability — Bethesda, Maryland
- Mental Health Crises in Youth With IDDs — San Diego, California
- Cooking Skills to Improve Long-Term Weight Loss in Young Adults With Intellectual Disabilities — Kansas City, Kansas
- Metformin for Antipsychotic-induced Weight Gain in Adults With Intellectual Disability — Toronto, Ontario
Explore by condition: All Intellectual Disability clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.